High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)Isao Taguchi, Ryozo Nagai, Masayasu Matsumoto et al.|Circulation|2018Cited by 242
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trialḰazunori Toyoda, Naoko Kumagai, Masayasu Matsumoto et al.|The Lancet Neurology|2019Cited by 216